本页面由Tiger Trade Technology Pte. Ltd.提供服务

Lyra Therapeutics, Inc.

0.4902
-0.0001-0.02%
成交量:4,089.00
成交额:2,370.94
市值:87.00万
市盈率:-0.02
高:0.6000
开:0.5900
低:0.4902
收:0.4903
52周最高:37.50
52周最低:0.3100
股本:177.49万
流通股本:132.37万
量比:12.83
换手率:0.31%
股息:- -
股息率:- -
每股收益(TTM):-22.9324
每股收益(LYR):-71.7474
净资产收益率:-404.48%
总资产收益率:-33.08%
市净率:-0.20
市盈率(LYR):-0.01

数据加载中...

2026/03/26

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/03/26

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/03/26

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/03/26

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/03/26

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/03/17

重要事件披露

Form 8-K - Current report
2026/02/27

重要事件披露

Form 8-K - Current report
2026/02/06

重要事件披露

Form 8-K - Current report
2026/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/13

重要事件披露

Form 8-K - Current report
2025/10/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/04

重要事件披露

Form 8-K - Current report
2025/08/22

重要事件披露

Form 8-K - Current report
2025/08/12

重要事件披露

Form 8-K - Current report
2025/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/01

重要事件披露

Form 8-K - Current report
2025/07/29

SEC问询函

Form CORRESP - Correspondence